Category: CovidienSyndicate content

Medtronic-Covidien: What does it mean for medtech? | The week in medtech M&A

June 18, 2014 by MassDevice

This week is all about Medtronic's blockbuster acquisition of Covidien for nearly $43 billion and the deal's wider implications for medtech; plus, Hill-Rom makes a move in Germany.

Analysis: What does the union of Medtronic and Covidien mean for medtech?

June 16, 2014 by MassDevice

Analysis: What does the union of Medtronic and Covidien mean for medtech?

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Op-ed: Medtronic/Covidien deal good for patients, Minnesota

June 17, 2014 by MassDevice

LifeScience Alley CEO Shaye Mandle writes that the recently announced marriage of Medtronic and Covidien is a boon for the North Star State.

Shaye Mandle

By: Shaye Mandle, President & CEO, LifeScience Alley

LifeScience Alley, the nation's largest regional life science industry association, welcomes the news that Medtronic, the world’s leading provider of medical technology products, services and solutions, is acquiring Covidien, a leading global healthcare technology and medical supplies provider.

Medtronic buyout holds $80M in golden parachutes for Covidien execs

June 17, 2014 by Brad Perriello

Medtronic's pending $43 billion acquisition of Covidien could trigger 'golden parachute' provisions worth nearly $80 million for Covidien's senior management team.

Medtronic buyout holds $80M in golden parachutes for Covidien execs

If the top executives at Covidien decide to leave the company after a $43 billion acquisition by Medtronic goes through, they'll do it under a golden parachute worth a collective $80 million, regulatory filings show.

Medtronic's OUS move becomes a political football | MassDevice.com On Call

June 17, 2014 by Arezu Sarvestani

Medtronic's pending acquisition of Covidien will see the company's headquarters moved to Ireland, and one political hopeful is blaming the Obama Administration for chasing innovation out of the U.S.

MassDevice.com On Call

Analysis: What does the union of Medtronic and Covidien mean for medtech?

June 16, 2014 by MassDevice

The merger of medical device giants Medtronic and Covidien has a range of implications both for those companies and for medtech in general, former Medtronic CEO Bill Hawkins tells MassDevice.com.

Analysis: What does the union of Medtronic and Covidien mean for medtech?

By Brad Perriello and Brian Johnson

UPDATED June 16, 2014, with additional comment from Leerink Partners analyst Danielle Antalffy.

Former Medtronic CEO Bill George bullish on Medtronic/Covidien deal

June 16, 2014 by Brian Johnson

See video

Former Medtronic (NYSE:MDT) CEO Bill George says the Covidien (NYSE:COV) deal is about more than inversion in this interview with Squawkbox on MSNBC.

Blockbuster: Medtronic in $43B deal to acquire Covidien

June 16, 2014 by Brad Perriello

Medtronic makes a big move with its $43 billion deal to acquire Covidien and its string of complementary medical device lines.

Blockbuster: Medtronic in $43B deal to acquire Covidien

Medtronic (NYSE:MDT) said yesterday that it agreed to acquire Covidien (NYSE:COV) in a cash-and-stock deal worth nearly $43 billion.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp